---

10:00 AM – 12:00 PM – Bill & Melinda Gates foundation symposium

 

12:00 – 1:30 pm – Lunch on your own

 

1:30 pm – 3:30pm – NIH Martin Delaney Collaboratories symposium

03:30- 04:00 PM – Coffee Break

04:00 – 05:00 PM – NIH Martin Delaney Collaboratories symposium

05:00 – 05:15 – Discussion break

05:15 – 06:30 PM – NIH Martin Delaney Collaboratories symposium

 

06:30 – 07:00 PM – Opening Lecture « Tribute to Timothy Ray Brown »

Welcoming message – Alain Lafeuillade, La Valette du Var, France – Mario Steveson, Miami, USA – David Margolis, Chapel Hill, USA – Karl Salzwedel, Bethesda, USA

Lessons learned from allogeneic stem cell transplantation in HIV+ patients – Gero Hütter, Germany

 

07:00 PM – Welcome dinner

08:00 – 10:00 AM Session 1: Basic Science of HIV Persistence

Moderators: Maria Salgado, Barcelona – SPA & Nancy Archin, Chapell Hill – USA
1st lecturer: Sequencing HIV: Significance and Impact- Sarah Palmer, Sydney – AUS
+ 7 oral communications

 

10:00 – 10:30 AM Break

 

10:30 AM – 12:30 PM Session 2: In Vitro and Animal Model Studies of HIV Persistence

Moderators: Ann Chahroudi, Yerkes – USA & Afam Okoye, Beaverton – USA
1st lecturer: CCR5 blockade in HIV cure – Jonah B. Sacha, Beaverton, USA
+ 7 oral communications

 

12:30 – 02:00 PM – Lunch

 

02:00 – 04:00 PM – Session 3: Virology of HIV Persistence

Moderators: Ya Chi Ho, Yale – USA & Mary Kearney, Frederick – USA
1st lecturer: HIV Persistence in women, an update – Nancie Archin, USA
+ 7 oral communications

 

04:00 – 05:00 PM – Young investigators dedicated session for oral presentations
05:00 – 07:30 PM – Poster session & free evening dinner

 

05:00 – 07:30 PM – Poster session & free evening dinner

08:00 – 10:00 AM Session 4: Immunology of HIV Persistence

Moderators: Katharine Bar, Philadelphia – USA & Bradley Jones, New York – USA
1st lecturer: Viral persistence and NK cells – Michaela Muller–Trutwin, Paris, France
+ 7 oral communications

 

10:00 – 10:30 AM Break

10:30 AM – 12:30 PM Session 5:  Drug Discovery Development & pharmacology

Moderators: Romas Geleziunas, Foster City – USA & Jan Van Luzen, London – GB
1st lecturer: IAP inhibitors to induce HIV expression – Richard Dunham, Chapel Hill, USA
+ 7 oral communications

 

12:30 – 02:00 PM –  Lunch

 

02:00 – 04:00 PM – Session 6: Cell & gene therapies

Moderators: Javier Martinez-Picado, Badalona – ESP & Paula Cannon, Los Angeles – USA
1st lecturer: It’s a mountain not a hill: Progress made in realizing AAV-delivered inhibitors for an HIV cure – Mathew Gardner, Jupiter, USA
+ 7 oral communications

 

04:00 – 05:00 PM – Young investigators dedicated session for oral presentations

 

05:00 – 07:30 PM – Poster session & free evening dinner

08:00 – 10:00 AM Session 7: Human Studies

Moderators: L.ydie Trautman, Beaverton – USA & D. Margolis, Chapell Hill – USA
1st lecturer: Challenges and Advances in Identification and Immune Targeting of HIV-Infected Cells: Implications for HIV Cure Therapies – Timothy Henrich, San Francisco, USA
+ 7 oral communications

 

10:00 – 10:30 AM Break

 

10:30 AM – 12:30 PM Session 8: Antibody & Immune based therapies

Moderators: Marina Caskey, Rockefeller – USA & Michael Farzan, San Diego – USA
1st lecturer: Broadly Neutralizing Antibodies for HIV Prevention, Therapy and Cure: 3BNC117 & 10-1074 Studies – Marina Caskey, New York , USA
+ 7 oral communications

 

12:30 – 01:00 PM –  Closing ceremony